Novo Nordisk A/S Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$145.74 | $174.55 | 16.65% | 3 | $351.20B |
| MRK | Merck | Outperform |
2
|
$125.23 | $130.51 | 11.00% | 11 | $317.21B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£109.14 | £165.99 | 48.27% | 16 | £169.19B |
| NOVN | Novartis | Hold |
10
|
CHF84.52 | CHF105.00 | 24.59% | 9 | CHF185.09B |
| ROG | Roche Holding | Hold |
16
|
CHF220.00 | CHF307.83 | 23.86% | 9 | CHF177.19B |
| ABT | Abbott Laboratories | Outperform |
9
|
$105.27 | $118.92 | 20.64% | 7 | $182.66B |
| PFE | Pfizer | Outperform |
2
|
$25.39 | $32.87 | 20.13% | 6 | $143.77B |
| AMGN | Amgen | Outperform |
4
|
$262.75 | $303.65 | 20.74% | 8 | $140.93B |
| SAN | Sanofi | Outperform |
16
|
85.23€ | 102.80€ | 26.72% | 9 | 106.41€B |
| MDT | Medtronic | Outperform |
11
|
$79.19 | $92.47 | 20.60% | 21 | $105.15B |
| BSX | Boston Scientific | Outperform |
11
|
$67.42 | $70.14 | 8.28% | 6 | $99.10B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.30 | $58.15 | 13.87% | 10 | $97.89B |
| CSL | CSL | Outperform |
12
|
$271.40 | $205.51 | -25.14% | 5 | $131.15B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$66.16 | $87.82 | 23.94% | 14 | $82.50B |
| GSK | GSK | Outperform |
12
|
£15.84 | £17.30 | 23.11% | 12 | £64.70B |
| SHW | Sherwin Williams | Outperform |
15
|
$309.38 | $317.38 | 9.81% | 9 | $78.61B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥4.54k | ¥5.24k | 27.87% | 0 | ¥8.70T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | ¥4.74k | 13.72% | 0 | ¥6.42T |
| PPG | PPG Industries | Outperform |
13
|
$135.11 | $159.04 | 18.42% | 1 | $31.79B |
| BIIB | Biogen | Outperform |
10
|
$190.52 | $299.62 | 53.26% | 13 | $27.69B |
| BAYN | Bayer | Hold |
5
|
26.24€ | 45.15€ | 21.95% | 4 | 25.78€B |
| HZNP | Horizon Therapeutics Public | - |
16
|
$115.69 | $116.50 | -100.00% | 0 | $23.58B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$145.16 | $245.24 | 48.11% | 7 | $18.36B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.96k | Rp5.67k | 1.53% | 25 | Rp992.32B |
| IPN | Ipsen | Outperform |
17
|
106.30€ | 127.95€ | 10.07% | 0 | 8.78€B |
| SOBI | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr259.40 | kr293.00 | 21.43% | 6 | kr86.43B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr598.00 | kr357.00 | 36.29% | 2 | kr45.84B |
| ARNA | Arena Pharmaceuticals | - |
6
|
$99.99 | $100.00 | -100.00% | 0 | $6.17B |
| GRF | Grifols | Outperform |
18
|
8.62€ | 18.48€ | 120.42% | 3 | 4.76€B |
| APN | Aspen Pharmacare Holdings | Outperform |
18
|
R219.20 | R202.49 | 5.16% | 1 | R90.67B |
| CLN | Clariant | Outperform |
18
|
CHF13.29 | CHF16.11 | 12.87% | 6 | CHF3.60B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$29.94 | $44.75 | 33.60% | 0 | $3.70B |
| 4403 | NOF | Buy |
18
|
¥2.16k | ¥7.63k | 31.36% | 0 | ¥563.06B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$38.65 | $69.00 | 60.41% | 0 | $2.62B |
| PFIZER | Pfizer | Outperform |
18
|
Rp4.11k | Rp4.53k | 19.98% | 3 | Rp207.63B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$5.36 | $6.13 | 39.93% | 1 | $1.78B |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.76 | $4.60 | 169.89% | 1 | $330.07M |
| NKTR | Nektar Therapeutics | Hold |
11
|
$1.32 | $2.75 | -24.24% | 2 | $171.69M |
| ABEO | Abeona Therapeutics | Buy |
8
|
$7.53 | $21.25 | 139.04% | 2 | $160.78M |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£32.37 | £0.00 | -100.00% | 0 | £3.30B |
| TXMD | TherapeuticsMD | - |
5
|
$2.26 | $5.00 | 3.10% | 0 | $27.14M |
| ORGS | Orgenesis | - |
6
|
$0.28 | $9.00 | -46.43% | 0 | $16.26M |
| ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | $16.00 | -100.00% | 0 | $8.48M |
| APVO | Aptevo Therapeutics | Buy |
-7
|
$0.77 | $7.38 | 58471.43% | 1 | $3.51M |
| ACMELAB | The ACME Laboratories | - |
15
|
70.30 | 0.00 | -100.00% | 0 | 17.31B |
| ACI | Advanced Chemical Industries | - |
12
|
148.80 | 0.00 | -100.00% | 0 | 13.84B |
| SQURPHARMA | Square Pharmaceuticals PLC. | Buy |
0
|
214.10 | 318.00 | 49.00% | 0 | 195.02B |
| SILCOPHL | Silco Pharmaceuticals | - |
0
|
17.40 | 0.00 | -100.00% | 0 | 2.21B |
| RENATA | Renata | Hold |
0
|
977.10 | 0.00 | 15.96% | 0 | 146.00B |
| BXPHARMA | Beximco Pharmaceuticals | Outperform |
0
|
117.70 | 153.50 | 30.42% | 0 | 62.05B |